CARL ZEISS MEDITEC AG - BR (AFX.DE) Stock Price & Overview

FRA:AFX • DE0005313704

Current stock price

23.54 EUR
-0.02 (-0.08%)
Last:

The current stock price of AFX.DE is 23.54 EUR. Today AFX.DE is down by -0.08%. In the past month the price decreased by -13.32%. In the past year, price decreased by -63.16%.

AFX.DE Key Statistics

52-Week Range23.22 - 69.9
Current AFX.DE stock price positioned within its 52-week range.
1-Month Range23.22 - 27.5
Current AFX.DE stock price positioned within its 1-month range.
Market Cap
2.105B
P/E
16.12
Fwd P/E
11.46
EPS (TTM)
1.46
Dividend Yield
2.33%

AFX.DE Stock Performance

Today
-0.08%
1 Week
-1.83%
1 Month
-13.32%
3 Months
-41.22%
Longer-term
6 Months -47.08%
1 Year -63.16%
2 Years -79.65%
3 Years -81.59%
5 Years -81.67%
10 Years -13.19%

AFX.DE Stock Chart

CARL ZEISS MEDITEC AG - BR / AFX Daily stock chart

AFX.DE Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to AFX.DE. When comparing the yearly performance of all stocks, AFX.DE is a bad performer in the overall market: 98.38% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AFX.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to AFX.DE. AFX.DE has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AFX.DE Earnings

On February 12, 2026 AFX.DE reported an EPS of 0.03 and a revenue of 467.00M. The company missed EPS expectations (-88.15% surprise) and missed revenue expectations (-4.5% surprise).

Next Earnings DateMay 11, 2026
Last Earnings DateFeb 12, 2026
PeriodQ1 / 2026
EPS Reported€0.03
Revenue Reported467M
EPS Surprise -88.15%
Revenue Surprise -4.50%

AFX.DE Forecast & Estimates

23 analysts have analysed AFX.DE and the average price target is 37.68 EUR. This implies a price increase of 60.07% is expected in the next year compared to the current price of 23.54.

For the next year, analysts expect an EPS growth of 1.24% and a revenue growth 2.21% for AFX.DE


Analysts
Analysts66.09
Price Target37.68 (60.07%)
EPS Next Y1.24%
Revenue Next Year2.21%

AFX.DE Groups

Sector & Classification

Index Membership

AFX.DE Financial Highlights

Over the last trailing twelve months AFX.DE reported a non-GAAP Earnings per Share(EPS) of 1.46. The EPS decreased by -17.51% compared to the year before.


Income Statements
Revenue(TTM)2.20B
Net Income(TTM)141.22M
Industry RankSector Rank
PM (TTM) 6.34%
ROA 4.15%
ROE 6.67%
Debt/Equity 0.27
Chartmill High Growth Momentum
EPS Q2Q%-83.33%
Sales Q2Q%-4.79%
EPS 1Y (TTM)-17.51%
Revenue 1Y (TTM)5.89%

AFX.DE Ownership

Ownership
Inst Owners24.4%
Shares89.44M
Float34.64M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About AFX.DE

Company Profile

AFX logo image Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.

Company Info

IPO: 2000-03-20

CARL ZEISS MEDITEC AG - BR

Goeschwitzer Strasse 51-52

Jena THUERINGEN DE

Employees: 5730

AFX Company Website

AFX Investor Relations

Phone: 493641220331

CARL ZEISS MEDITEC AG - BR / AFX.DE FAQ

What does AFX do?

Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.


What is the stock price of CARL ZEISS MEDITEC AG - BR today?

The current stock price of AFX.DE is 23.54 EUR. The price decreased by -0.08% in the last trading session.


What is the dividend status of CARL ZEISS MEDITEC AG - BR?

CARL ZEISS MEDITEC AG - BR (AFX.DE) has a dividend yield of 2.33%. The yearly dividend amount is currently 0.6.


What is the ChartMill rating of CARL ZEISS MEDITEC AG - BR stock?

AFX.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Would investing in CARL ZEISS MEDITEC AG - BR be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AFX.DE.


What is CARL ZEISS MEDITEC AG - BR worth?

CARL ZEISS MEDITEC AG - BR (AFX.DE) has a market capitalization of 2.11B EUR. This makes AFX.DE a Mid Cap stock.